Wellcome Trust Sanger Institute in Cambridge
AstraZeneca dives into gene editing
January 29, 2015Research and Development, Sales and Marketing AstraZeneca, Intellia Therapetics, Novartis, Thermo Fisher Scientific, Wellcome Trust Sanger Institute in Cambridge, Whitehead, broad institute, crispr, the Innovative Genomics Initiative in California
AstraZeneca is looking to harness the power of a pioneering genome-editing tool in a series of new collaborations. The UK …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
